Brief: BioInvent Q2 Sales SEK 4.6 Million
29/08/2024 07:00
Aug 29 (Reuters) - BioInvent Q2 adjusted EPS SEK -2.09. * Q2 adjusted free cash flow SEK -119.2 million * Q2 net income SEK -137.3 million
BINV — BioInvent International AB News Story
0.000.00%
Last trade - 00:00- SEK1.59bn
- SEK1.14bn
- SEK226.50m